March 27, 2019
Liveyon Blames FDA

The Danger of Using Donor-derived Materials Without Good Quality Control: the Liveyon Debacle – Part Three

In the past two posts (Part One and Part Two) I have covered details about a serious lapse in quality control on the part of Genetech, the source of contaminated cord blood-derived products, which was injected into 15 patients who have developed serious infections, as tracked by the CDC. Genetech sold the donor-derived cord blood...
Read More